And by not having to deal with insurance, patients can avoid long wait times, price hikes and more
The report shows that the number of 12- to 25-year-olds using any GLP-1 drug including older medications first approved to treat diabetes in 2005 and for weight loss in 2014 climbed from about 8,700 a month in 2020 to more than 60,000 a month in 2023, a nearly 600% increase
As of early 2026, the keratinocyte mechanism for GLP-1 facial aging specifically remains hypothesis-stage rather than settled
Nutrition Guidance: He offers evidence-based advice on nutrition strategies for enhancing performance, improving body composition, and overall health
Clinical trials using the Patient Health Questionnaire 9 (PHQ-9) found participants taking semaglutide, tirzepatide were 37% less likely to progress to more severe depression than those receiving placebo
Doctronic.ai is transforming the way patients receive care by offering 24/7 telehealth video visits with licensed doctors across all 50 states